Ester Hammond
Professor of Molecular Cancer Biology
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Positions (2)
Ester Hammond
University of Oxford
10 months ago
A funded PhD position is available in the laboratory of Professor Ester Hammond at the University of Oxford. The research focuses on exploring the biology underpinning the response to hypoxia in tumours and investigating how these mechanisms can be targeted to improve radiotherapy outcomes. This opportunity is ideal for candidates interested in molecular cancer biology, tumour microenvironment, and translational approaches to cancer therapy. The position is fully funded and will commence in October 2026. Applicants should have a strong background in biology or a related discipline and a keen interest in cancer research, particularly in the areas of tumour hypoxia and radiotherapy. The project aims to advance understanding of the molecular pathways involved in tumour response to low oxygen conditions and to identify novel strategies for enhancing the effectiveness of radiotherapy in cancer treatment. The University of Oxford provides a vibrant research environment with access to state-of-the-art facilities and a collaborative academic community. The successful candidate will join a leading research group and benefit from mentorship by Professor Ester Hammond, an expert in molecular cancer biology. For more information and to apply, please visit the provided LinkedIn or application link. Interested candidates are encouraged to review the application instructions and prepare the necessary materials. The application deadline is December 28, 2025.
10 months ago
Ester Hammond
University of Oxford
A postdoctoral position is available in the laboratory of Professor Ester Hammond at the University of Oxford, funded by Brain Research UK. The research focuses on characterising the biological response to hypoxia and understanding how these responses impact the effectiveness of existing and novel therapy combinations. The project will involve determining the mechanism of action of new therapeutics and translating findings through increasingly complex biological models. This is an excellent opportunity for candidates interested in molecular cancer biology, hypoxia, and translational research. The University of Oxford provides a vibrant research environment and access to cutting-edge facilities. Applicants should have a PhD in a relevant field and experience in biological research related to cancer or therapeutics. For more information and to apply, please visit the official University of Oxford recruitment portal. The position is fully funded by Brain Research UK, with further details available in the full job description.
Articles (13)
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (10)
Stephen Faulkner
Professor of Chemistry
University of Oxford
Samuel Bader
Relay Therapeutics Inc
Deborah Sneddon
Lecturer
University of Sussex
Matthias Schiedel
Professor
Technische Universität Braunschweig
Ewen Calder
University of Oxford
Pascal Heitel
-
Stuart J. Conway
University of California, Los Angeles
Wilian Cortopassi
-
Geoff Higgins
University of Oxford
Francesca M. Buffa
Full Professor, Principal Investigator, Computational Biology/Systems Biology/Integrative Genomics
-
Make your next move.
Prepare your application
Review drafts before you send them.